EcoDrugPlus

Trace Amine Associated Receptor 1

Ensembl ID : ENSACIG00000001126
Gene Symbol: TAAR1
2 Cross references
381 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSACIG00000001150
Gene Symbol: TAAR1
1 Cross references
381 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSACIG00000001099
Gene Symbol: TAAR1
1 Cross references
365 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSACIG00000001084
Gene Symbol: TAAR1
1 Cross references
396 Possible Orthologues:

Transforming Growth Factor, Beta Receptor 1 B

Ensembl ID : ENSACIG00000008704
Gene Symbol: TGFBR1B
1 Cross references
205 Possible Orthologues:

Transient Receptor Potential Cation Channel, Subfamily A, Member 1b

Ensembl ID : ENSACIG00000000189
Gene Symbol: TRPA1B
1 Cross references
201 Possible Orthologues:

Tryptophan Hydroxylase 1 (Tryptophan 5-Monooxygenase) A

Ensembl ID : ENSACIG00000011391
Gene Symbol: TPH1A
1 Cross references
202 Possible Orthologues:

Tryptophan Hydroxylase 1b

Ensembl ID : ENSACIG00000008600
Gene Symbol: TPH1B
1 Cross references
177 Possible Orthologues:

Tubulin, Alpha 8 Like 2

Ensembl ID : ENSACIG00000012688
Gene Symbol: TUBA8L2
1 Cross references
158 Possible Orthologues:

Tubulin, Beta 2a Class Iia

Ensembl ID : ENSACIG00000016390
Gene Symbol: TUBB2
1 Cross references
301 Possible Orthologues:

Tubulin, Beta 5

Ensembl ID : ENSACIG00000013639
Gene Symbol: TUBB5
1 Cross references
221 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSACIG00000015627
Gene Symbol: TP53
1 Cross references
231 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).